Allergies News and Research

Latest Allergies News and Research

Researchers continue a national study to evaluate COVID-19 vaccination safety pre-and post-delivery

With the SARS-CoV-2 pandemic ongoing, researchers at University of California San Diego School of Medicine, in collaboration with the American Academy of Allergy Asthma and Immunology, will continue a national study to evaluate the safety of COVID-19 vaccinations during pregnancy, and monitor immune response for mother and baby following vaccinations.

23 Jun 2022

Childhood bronchitis increases the risk of lung diseases in adult life

Bronchitis in early childhood has been found to increase the risk of lung diseases in middle age according to research from the Allergy and Lung Health Unit at the University of Melbourne.

21 Jun 2022

How specific comorbidities impact severity of COVID-19

Researchers identify the association between severe COVID-19 and specific comorbidities.

20 Jun 2022

UTSW study provides a potential avenue for the development of new antivirals against influenza

A collaborative study from UT Southwestern scientists has identified a new function for a protein called TAO2 that appears to be key to inhibiting replication of the influenza virus, which sickens millions of individuals worldwide each year and kills hundreds of thousands.

20 Jun 2022

GPR183 gene a novel drug target for severe COVID-19

In a recent study posted to the bioRxiv* pre-print server, researchers provide the first preclinical evidence of the usefulness of antagonists of G-protein coupled receptor 183 (GPR183), also known as Epstein-Barr virus-induced gene 2 (EBI2), in reducing coronavirus disease 2019 (COVID-19) severity.

17 Jun 2022

UB program secures $12.8 million to improve the quality of global HIV research

The National Institutes of Health (NIH) has awarded $12.8 million to the University at Buffalo School of Pharmacy and Pharmaceutical Sciences to lead a clinical pharmacology quality assurance program for NIH-funded laboratories and research networks across the globe conducting HIV and infectious disease research.

16 Jun 2022

Oral immunotherapy for peanut allergies is highly effective when started for infants under 12 months

UBC researchers demonstrated in 2019 that pre-schoolers can safely overcome peanut allergies with a treatment called oral immunotherapy.

16 Jun 2022

Stanford researcher outlines pollution and climate change threats to children's health

Horror stories of children trapped in hot cars make headlines, but air pollution and impacts from a changing climate are more constant threats.

15 Jun 2022

Study links SARS-CoV-2 specific T cells with inflammation and reduced lung function in long COVID

A new study published in today’s issue of PLoS Pathogens is the first to link SARS-CoV-2 specific T cells to lung function and those who suffer from long-term COVID symptoms (PASC). Long-covid currently affects hundreds of millions of Americans.

9 Jun 2022

Pulmonary and primary care experts aim to reduce the time to diagnose interstitial lung diseases

The American College of Chest Physicians (CHEST) and Three Lakes Foundation are announcing a steering committee of experts in the fields of pulmonary medicine and primary care medicine to lead an initiative called Bridging Specialties™: Timely Diagnosis for ILD Patients.

9 Jun 2022

Ventilation key to reducing COVID-19 spread in schools

Recently, Centres for Disease Control and Prevention (CDC) evaluated the aforementioned data on ventilation improvement strategies implemented in kindergarten through grade 12 (K–12) public schools in the United States.

8 Jun 2022

New technology may enable rapid diagnosis of Ebola virus

A new tool can quickly and reliably identify the presence of Ebola virus in blood samples, according to a study by researchers at Washington University School of Medicine in St. Louis and colleagues at other institutions.

8 Jun 2022

Targeted dietary measures can reduce the symptom burden in allergic reactions, trial shows

Micronutrient deficiencies can promote inflammation and render the immune system particularly sensitive to allergenic substances.

8 Jun 2022

People with HIV are at greater risk of breakthrough COVID-19 infections after vaccination

People with HIV have a higher rate of breakthrough COVID-19 infections after vaccination, compared to people without HIV, according to findings from a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

7 Jun 2022

New analytical method sheds light on enduring mystery about type 2 diabetes

Researchers at Oregon State University have invented a new analytical method that sheds light on an enduring mystery regarding type 2 diabetes: Why some obese patients develop the disease and others don't.

6 Jun 2022

Fecal Microbiota Transplantation found to be an optimal cost-effective treatment for recurrent C. difficile infection

Research recently published in Clinical Infectious Diseases from the University of Minnesota Medical School has found that Fecal Microbiota Transplantation, or FMT, is an optimal cost-effective treatment for first recurrent Clostridioides difficile infection, or CDI or C-Diff.

3 Jun 2022

Immune responses may exist on a finer spectrum than previously believed

Researchers from McGill University and the US National Cancer Institute (NCI) have made some surprising discoveries about our immune system.

3 Jun 2022

The effect of BNT162b2 mRNA COVID-19 vaccine on human semen

Scientists from Italy have recently analyzed the effect of the mRNA-based COVID-19 vaccine on the semen quality of adult men.

3 Jun 2022

NIH sponsors the trial of monoclonal antibody to prevent asthma exacerbations in urban youth

The National Institutes of Health has launched a clinical trial testing whether a monoclonal antibody, dupilumab, can reduce asthma attacks and improve lung function and asthma symptoms in children with poorly controlled allergic asthma who live in low-income urban neighborhoods.

2 Jun 2022

Combination bNAb therapy may offer a future alternative to daily ART for people living with HIV

Individuals with HIV who began taking antiretroviral therapy (ART) in the early stages of infection achieved a lengthy period of HIV suppression without ART after receiving two broadly neutralizing anti-HIV antibodies (bNAbs), according to a small study published today in the journal Nature.

1 Jun 2022

Allergies News and Research

Latest Allergies News and Research

Researchers continue a national study to evaluate COVID-19 vaccination safety pre-and post-delivery

Childhood bronchitis increases the risk of lung diseases in adult life

How specific comorbidities impact severity of COVID-19

UTSW study provides a potential avenue for the development of new antivirals against influenza

GPR183 gene a novel drug target for severe COVID-19

UB program secures $12.8 million to improve the quality of global HIV research

Oral immunotherapy for peanut allergies is highly effective when started for infants under 12 months

Stanford researcher outlines pollution and climate change threats to children's health

Study links SARS-CoV-2 specific T cells with inflammation and reduced lung function in long COVID

Pulmonary and primary care experts aim to reduce the time to diagnose interstitial lung diseases

Ventilation key to reducing COVID-19 spread in schools

New technology may enable rapid diagnosis of Ebola virus

Targeted dietary measures can reduce the symptom burden in allergic reactions, trial shows

People with HIV are at greater risk of breakthrough COVID-19 infections after vaccination

New analytical method sheds light on enduring mystery about type 2 diabetes

Fecal Microbiota Transplantation found to be an optimal cost-effective treatment for recurrent C. difficile infection

Immune responses may exist on a finer spectrum than previously believed

The effect of BNT162b2 mRNA COVID-19 vaccine on human semen

NIH sponsors the trial of monoclonal antibody to prevent asthma exacerbations in urban youth

Combination bNAb therapy may offer a future alternative to daily ART for people living with HIV

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in